Rare diseases
Investigational molecules
Locations
Gasverksgatan 1, St Peters Kloster, 222 29 Lund, Sweden
SpectraCure AB (publ) focuses on clinical research in primary localised prostate cancer and recurrent prostate cancer, with an emphasis on organ-confined and locally recurrent disease.
The sponsor’s research activity is centered on treatment approaches for prostate tumours that remain confined to the gland or return after prior therapy.
SpectraCure AB (publ) runs clinical trials in conditions such as Prostate cancer recurrent, Prostate cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
